Orthofix Cautiously Optimistic For 2020 Second Half Growth

Orthofix's logo

Orthofix reported orthopedic revenue of USD $73.1 million, -36.9% vs. 2Q19. COVID significantly impacted the company's second-quarter, and while sequential month trends improved, Orthofix exited June down -15%. Sales in July declined -10% versus the prior year. The deformity correction focus of the company's trauma portfolio acted as a...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us